Search - tctmd.com

Displaying 481 - 500 of 572

Sort: Relevancy | Date

News Daily News

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

March 05, 2014

News Daily News

Meta-analysis Links Off-Hour Acute MI Presentation to Higher Mortality

February 06, 2014

News Conference News AHA 2013

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Yael L. Maxwell

November 20, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

Caitlin E. Cox

October 25, 2013

News Daily News

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Caitlin E. Cox

October 11, 2013

News Daily News

Better Door-to-Balloon Times Do Not Translate to Lower Mortality in STEMI Patients

Jason Kahn

September 05, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

L.A. McKeown

August 19, 2013

News Daily News

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Yael L. Maxwell

August 19, 2013

Presentation

Routine Early Eptifibatide vs. Delayed Provisional Use at PCI in High-Risk NSTE-ACS Patients

Presenter: A. Bagai

August 06, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Nonsystem Delays in STEMI Patients Predict In-Hospital Mortality

Yael L. Maxwell

April 19, 2013

News Daily News

SCAAR Turns 20: PCI Expanded to Higher-Risk Patients with No Mortality Trade-off

March 25, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

Advertisement

DEFER-STEMI Published: Delayed Stenting Improves Outcomes in Higher-Risk STEMI Patients

Meta-analysis Links Off-Hour Acute MI Presentation to Higher Mortality

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Weekend vs. Weekday Admission Carries No Added Risk for NSTE ACS Patients

High-Risk Subgroups Derive Kidney Protection from Rosuvastatin

Better Door-to-Balloon Times Do Not Translate to Lower Mortality in STEMI Patients

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

La Administración Upstream de Eptifibatida se asoció a Mejores Resultados en Pacientes PCI

Routine Early Eptifibatide vs. Delayed Provisional Use at PCI in High-Risk NSTE-ACS Patients

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Nonsystem Delays in STEMI Patients Predict In-Hospital Mortality

SCAAR Turns 20: PCI Expanded to Higher-Risk Patients with No Mortality Trade-off

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content